83
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy

, , , , , , , , & show all
Pages 205-214 | Published online: 02 Aug 2013

References

  • LudwigHVan BelleSBarrett-LeePThe European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsEur J Cancer200440152293230615454256
  • AaproMSCameronDAPettengellREORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumoursEur J Cancer200642152433245316750358
  • CaroJJSalasMWardAGossGAnemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative reviewCancer200191122214222111413508
  • HarperPLittlewoodTAnaemia of cancer: impact on patient fatigue and long-term outcomeOncology200569Suppl 22716244504
  • CalabrichAKatzAManagement of anemia in cancer patientsFuture Oncol20117450751721463140
  • AaproMSLinkHSep 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agentsOncologist200813Suppl 3333618458123
  • SchrijversDDeSamblanx HRoilaFESMO Guidelines Working GroupErythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for useAnn Oncol201021Suppl 5v244v24720555090
  • AaproMÖsterborgAGascónPLudwigHBeguinYPrevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. ironAnn Oncol20122381954196222575608
  • SchrijversDManagement of anemia in cancer patients: transfusionsOncologist201116Suppl 3121821930830
  • Amgen Europe BVAranesp® Annex I Summary of Product CharacteristicsThe NetherlandsAmgen Europe BV2012 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000332/WC500026149.pdfAccessed June 27, 2013
  • RizzoJDSomerfieldMRHagertyKLUse of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline updateJ Clin Oncol200826113214917954713
  • CastaigneSTouraniJMDelalogeSHennequinCZureikMLemariéEHigh prevalence of anaemia among French hospitalized cancer patients: A one-day cross-sectional surveyHaematologica200792Suppl 228 Abstract 0077
  • SchmitzSChatsiproiosDSandermannALinkHHigh prevalence of anemia among cancer patients in outpatient clinics in Germany: A two-day cross-sectional surveyOnkologie200831Suppl 4220 Abstract
  • VerbekeNBeguinYWildiersHHigh prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)Support Care Cancer2012201232821107613
  • SteegmannJLSánchez TorresJMColomerRPrevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish surveyClin Transl Oncol201315647748323263906